G2 Capital Management’s Agilon Health AGL Stock Holding History

G2 Capital Management’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-556	Closed	-$14.3K	–	72
2025 Q3	$14.3K	Hold	556	–	–	﹤0.01%	70
2025 Q2	$32K	Hold	556	–	–	0.01%	64
2025 Q1	$60.2K	Hold	556	–	–	0.02%	64
2024 Q4	$26.4K	Hold	556	–	–	0.01%	62
2024 Q3	$54.6K	Hold	556	–	–	0.02%	62
2024 Q2	$90.9K	Hold	556	–	–	0.03%	63
2024 Q1	$84.8K	Hold	556	–	–	0.03%	64
2023 Q4	$174K	Hold	556	–	–	0.06%	62
2023 Q3	$247K	Hold	556	–	–	0.11%	41
2023 Q2	$241K	Sell	556 -109	-16%	-$61.3K	0.11%	43
2023 Q1	$395K	Sell	665 -335	-34%	-$188K	0.17%	43
2022 Q4	$404K	Sell	1,000 -242	-19%	-$113K	0.15%	51
2022 Q3	$727K	Hold	1,242	–	–	0.34%	31
2022 Q2	$678K	Hold	1,242	–	–	0.32%	31
2022 Q1	$787K	Hold	1,242	–	–	0.34%	31
2021 Q4	$838K	Buy	+1,242	New	+$756K	0.31%	31

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

G2 Capital Management's AGL Position: Q4 2025 in Review

G2 Capital Management sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 556 shares — an estimated $14.3K sold.

G2 Capital Management first reported a position in AGL in Q4 2021 and held it in 16 quarters. The position peaked at $838K in Q4 2021. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

G2 Capital Management reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
G2 Capital Management sold 556 Agilon Health shares in Q4 2025, an estimated $14.3K.
G2 Capital Management first reported a position in Agilon Health in Q4 2021 and held it in 16 quarters.
G2 Capital Management's Agilon Health position peaked at $838K in Q4 2021.
194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on G2 Capital Management's 13F filing for Q4 2025, filed 23 Jan 2026.